Trista Morrison
Responsable des Ressources Humaines chez VOYAGER THERAPEUTICS, INC.
Profil
Trista Morrison is currently the Director at Network of Tyrosinemia Advocates, Inc. and the Chief of Staff & SVP Corporate Affairs at Voyager Therapeutics, Inc. She previously worked as the Director-Corporate Communications at Ironwood Pharmaceuticals, Inc., the Head-Media Relations at Gemin X Pharmaceuticals US, Inc., and the Chief Communications Officer at Saniona AB.
Ms. Morrison completed her undergraduate degree at Tulane University (Louisiana).
Postes actifs de Trista Morrison
| Sociétés | Poste | Début |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Responsable des Ressources Humaines | - |
| Network of Tyrosinemia Advocates, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Trista Morrison
| Sociétés | Poste | Fin |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Public Communications Contact | - |
| SANA AB | Public Communications Contact | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Public Communications Contact | - |
Formation de Trista Morrison
| Tulane University (Louisiana) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| SANA AB | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
| Network of Tyrosinemia Advocates, Inc. |
